Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Colorectal Cancer Patients

Launched by FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Sep 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how the amount of fat and muscle in the abdomen can help predict outcomes for patients with colorectal cancer. Researchers believe that having too much fat around the organs (visceral fat) and not enough muscle (sarcopenia) can lead to more complications after surgery and affect overall survival. By using imaging techniques like CT scans to measure these areas, doctors hope to create personalized treatment plans that can improve surgery results and long-term recovery for patients.

To be eligible for this study, participants must be at least 18 years old and have a confirmed diagnosis of colorectal cancer. They should not have received any treatments like chemotherapy or radiation before joining the trial, and their cancer should not be at an advanced stage. If you choose to participate, the study will involve analyzing your pre-operative CT images to help doctors better understand how your body's fat and muscle levels could impact your treatment and recovery. This research aims to provide more tailored care for colorectal cancer patients, ultimately improving their outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1, Diagnosis of colorectal cancer confirmed by pathology or cytology;
• • 2, aged \>18 years;
• • 3, not received chemotherapy, radiotherapy, targeted therapy or immunotherapy;
• • 4, post-operative pathological stages other than stage IV, or no liver, lung or other organs as confirmed by CT, MRI, B-ultrasound imaging.
• • 5, patients who have pre-operative CT examination data kept in our hospital.
• Exclusion Criteria:
• • 1, Poor quality of preoperative CT images;
• • 2, refusal to participate in this study.